CompletedNot applicableNCT05722847

Risk Stratification for Patients With Hospital-diagnosed Advanced Lung Cancer

This study explores whether supportive care interventions that might reduce rehospitalization could be implemented and feasible, in subjects within a high-risk group of subjects with newly diagnosed hospitalized advanced lung cancer (ALC). This study screened 50 subjects from health records and consented to 15 of these screened subjects. These 15 subjects responded to PRO questionnaires.

Checked against the public recordLast updated May 25, 2025 · Source: ClinicalTrials.gov

StatusCompleted
PhaseNot applicable
U.S. locations1
SponsorUNC Lineberger Comprehensive Cancer Center
01
Study overview

What this study is about

Purpose
Not specified
Study type
Observational
Phase
Not applicable
Sponsor
UNC Lineberger Comprehensive Cancer Center
Interventions being studied
Not specified
02
Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

03
Public criteria

Who may be able to participate

Inclusion Criteria for Patient Participants: 1. Age ≥ 18 years at the time of screening. 2. Hospital-diagnosed Advanced lung cancer with histological confirmation of disease or suspected lung cancer in the opinion of the treating oncologist. For PROs only 1\. Able to complete a web-based or telephonic symptom survey. Exclusion Criteria for Patient Participants: 1\. Enrollment in hospice upon discharge from the index hospitalization For PROs only 1. Inability to read or speak English. 2. Dementia, altered mental status, or any psychiatric condition as determined by the clinical or study team that would prohibit the understanding or rendering of informed consent. 3. Current incarceration. 4. Any condition that would prohibit the patient from completing PROs Inclusion Criteria for Health Care Provider Participants: 1\. Thoracic medical oncology physicians, advance practice providers, and nurse navigators work in the study site and respond to the survey that assesses acceptability.

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

04
Study sites

U.S. locations

  • UNC LinebergerChapel Hill, North Carolina

Source and freshness
Processed from ClinicalTrials.gov. Last public update: May 25, 2025. Always confirm current availability with the study team.

View original record ↗